Page 3 - எங்களுக்கு தேசிய நிறுவனம் ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The researchers said the tests show the vaccine was safe to use and produced an immune response, but cautioned that more testing is necessary. PET scan of a human brain with Alzheimer’s disease. (Photo by US National Institute on Aging, Alzheimer’s Disease Education and Referral Center) (CN) Alzheimer’s disease is one of the leading causes of death in the U.S. but the results of a new breakthrough vaccine announced Monday shows promise in the effort to curb the deadly brain disorder. Biotech company Axon Neuroscience released the results of its Phase II testing of its vaccine in the journal Nature Aging. The two-year trial, involving 196 patients from eight European countries, was demonstrated to be safe and effective with those suffering from mild Alzheimer’s disease.

Christopher roweNational institute onUs national institute onAustin healthDrug administrationReferral centerDisease educationAxon neuroscienceNational instituteNeurofilament light chainகிறிஸ்டோபர் ரோதேசிய நிறுவனம் ஆன்எங்களுக்கு தேசிய நிறுவனம் ஆன்ஆஸ்டின் ஆரோக்கியம்பரிந்துரை மையம்நோய் கல்வி